KOSDAQ - Delayed Quote KRW

KOLMAR BNH Co.,Ltd. (200130.KQ)

13,490.00

-270.00

(-1.96%)

At close: April 30 at 3:30:30 PM GMT+9

Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement

SEOUL, South Korea, November 25, 2024--Kolmar BNH is committed to sustainable research and development, investing in eco-friendly products using green technologies

Business Wire 5 months ago

200130.KS
HemoHim Manufacturer Kolmar BNH Receives NAI Classification from the US FDA

SEOUL, South Korea, October 21, 2024--HemoHim Manufacturer, Kolmar BNH obtained a No Action Indicated (NAI) classification for its Sejong plant following an inspection by the FDA.

Business Wire 6 months ago

200130.KS
HemoHim's Global Market Success Rooted in Rigorous Quality Control

SEOUL, South Korea, August 23, 2024--HemoHim's huge success on the global stage is largely attributed to its meticulous quality control.

Business Wire 8 months ago

200130.KS
Kolmar BNH Expedites European Market Expansion with its Technology-Driven HemoHIM G

SEOUL, South Korea, July 24, 2024--Kolmar BNH widens global reach for HemoHIM G, immune-boosting and fatigue-fighting product, by expanding into SEA and Europe.

Business Wire 9 months ago

200130.KS
Kolmar BNH Sharpens Global Competitiveness with Dual Functionality of HemoHIM

SEOUL, South Korea, June 21, 2024--Kolmar BNH secured approval from the Ministry of Food and Drug Safety for the fatigue-improving function of the HemoHIM.

Business Wire 10 months ago

200130.KQ
-1.96%
Kolmar BNH Expands Its Global Market by Launching HemoHIM G in Taiwan

SEOUL, South Korea, May 28, 2024--Kolmar BNH launches HemoHIM G, expanding its presence in the global market.

Business Wire 10 months ago

200130.KS

Performance Overview

Return	200130.KQ	KOSPI Composite Index (^KS11)
YTD	+19.59%	+6.55%
1-Year	-13.13%	-5.03%
3-Year	-58.81%	-5.14%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

KOLMAR BNH Co.,Ltd. (200130.KQ)

Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement

HemoHim Manufacturer Kolmar BNH Receives NAI Classification from the US FDA

HemoHim's Global Market Success Rooted in Rigorous Quality Control

Kolmar BNH Expedites European Market Expansion with its Technology-Driven HemoHIM G

Kolmar BNH Sharpens Global Competitiveness with Dual Functionality of HemoHIM

Kolmar BNH Expands Its Global Market by Launching HemoHIM G in Taiwan

Performance Overview